Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BG.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.61ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.74ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.62ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.13.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAZENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.38.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BT.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.55ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.76ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.6.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BS.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.5.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.513ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.338ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.284ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.9.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.498ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.184ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.187ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
D.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AE.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used